Rubric Capital Management LP Collegium Pharmaceutical, Inc Transaction History

Rubric Capital Management LP

$6.05 Billion
Q4 2024

A detailed history of Rubric Capital Management LP transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Rubric Capital Management LP holds 2,350,000 shares of COLL stock, worth $67.7 Million. This represents 1.11% of its overall portfolio holdings.

Number of Shares

2,350,000

Previous 1,250,000 88.0%

Holding current value

$67.7 Million

Previous $48.3 Million 39.39%

% of portfolio

1.11%

Previous 1.35%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$28.61 - $41.86 $31.5 Million - $46 Million	1,100,000 Added 88.0%	2,350,000 $67.3 Million
Q3 2024 Nov 13, 2024	SELL	$31.4 - $39.07 $34 Million - $42.3 Million	-1,083,500 Reduced 46.43%	1,250,000 $48.3 Million
Q2 2024 Aug 13, 2024	BUY	$31.36 - $39.99 $15.7 Million - $20 Million	499,473 Added 27.23%	2,333,500 $75.1 Million
Q1 2024 May 10, 2024	SELL	$31.23 - $40.91 $28.9 Million - $37.8 Million	-924,226 Reduced 33.51%	1,834,027 $71.2 Million
Q4 2023 Feb 13, 2024	SELL	$21.16 - $30.8 $8.82 Million - $12.8 Million	-416,747 Reduced 13.13%	2,758,253 $84.9 Million
Q3 2023 Nov 14, 2023	SELL	$21.23 - $24.28 $5.31 Million - $6.07 Million	-250,000 Reduced 7.3%	3,175,000 $71 Million
Q2 2023 Aug 11, 2023	BUY	$21.06 - $24.0 $3.18 Million - $3.62 Million	150,832 Added 4.61%	3,425,000 $73.6 Million
Q1 2023 May 12, 2023	SELL	$23.0 - $29.88 $1.37 Million - $1.78 Million	-59,460 Reduced 1.78%	3,274,168 $78.5 Million
Q3 2022 Nov 14, 2022	BUY	$15.46 - $20.1 $1.16 Million - $1.51 Million	75,000 Added 2.3%	3,333,628 $53.4 Million
Q2 2022 Aug 15, 2022	BUY	$14.22 - $20.88 $3.68 Million - $5.4 Million	258,628 Added 8.62%	3,258,628 $57.7 Million
Q1 2022 May 13, 2022	BUY	$17.2 - $22.5 $6.77 Million - $8.85 Million	393,500 Added 15.1%	3,000,000 $61.1 Million
Q3 2021 Nov 12, 2021	BUY	$17.75 - $25.39 $3.31 Million - $4.73 Million	186,286 Added 7.7%	2,606,500 $51.5 Million
Q1 2021 May 14, 2021	BUY	$19.25 - $26.1 $9.51 Million - $12.9 Million	493,931 Added 25.64%	2,420,214 $57.4 Million
Q2 2020 Aug 10, 2020	BUY	$15.49 - $23.51 $11 Million - $16.8 Million	712,871 Added 58.75%	1,926,283 $33.7 Million
Q1 2020 May 14, 2020	BUY	$13.89 - $25.45 $16.9 Million - $30.9 Million	1,213,412 New	1,213,412 $19.8 Million

Others Institutions Holding COLL

# of Institutions

246

Shares Held

37.2M

Call Options Held

59.3K

Put Options Held

9.5K

View Full List

About COLLEGIUM PHARMACEUTICAL, INC

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $984M
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

More about COLL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rubric Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rubric Capital Management LP with notifications on news.

Account

Rubric Capital Management LP Collegium Pharmaceutical, Inc Transaction History